0 a medical condition in which areas of the skin lose pigment (= the substance that gives it colour), causing them to appear white:
Vitiligo patients are also more likely to suffer from autoimmune disease.
I t is also still possible that anti-melanocyte antibodies arise from an immune reaction to damaged pigment cells but play no part in vitiligo aetiology.
The exact role of anti-melanocyte antibodies in the pathogenesis of vitiligo remains unresolved.
This article focuses on the immunological mechanisms that might play a part in the aetiology of vitiligo.
Some also offer support to vitiligo sufferers and their families, as well as providing information about the disorder.
The conditions range from facial vitiligo through rheumatoid arthritis to quadriplegia.
This review presents and discusses the evidence for immunological pathomechanisms in vitiligo.
In this context, research into the immunopathomechanisms in vitiligo might play an important part in the development of effective therapies for melanoma.
